H.R. 8840

Fair Care Act of 2026

Sponsor: Bruce Westerman · 0 cosponsors

Follow this bill

Official summary

No official summary yet.

Text of the bill

Expand all

I Modernization of health savings accounts

A Modernization of health savings accounts and contributions

B Assistance to health savings accounts

II Improving Private Health Insurance

A Maintaining Protections for Patients with Preexisting Conditions

B Expanding Coverage Options

C Improving Commercial Health Insurance

III Competition, Transparency and Accountability

A Provider and Insurer Competition

B Price Transparency

C Prescription Drug Competition and Innovation

Sec. 349. Regulation of manufacturer-sponsored co-pay contributions

Notwithstanding any other provision of law, the Secretary of Health and Human Services may establish a mechanism to regulate drug manufacturers’ financial contributions to patient out-of-pocket costs, such as drug co-pays.

D Prescription Drug and Pharmacy Benefit Manager Transparency

E Medicare and Medicaid Prescription Drug Reforms

F Medical Malpractice Reform

IV Medicare and Medicaid Reforms

A Medicaid Reforms

B Medicare Reforms

C Medicare Choice and Competition

D Telehealth Improvements and Expansion